Literature DB >> 28855100

Modelling iron mismanagement in neurodegenerative disease in vitro: paradigms, pitfalls, possibilities & practical considerations.

Sinead Healy1, Jill M McMahon1, Una FitzGerald2.   

Abstract

Although aberrant metabolism and deposition of iron has been associated with aging and neurodegeneration, the contribution of iron to neuropathology is unclear. Well-designed model systems that are suited to studying the putative pathological effect of iron are likely to be essential if such unresolved details are to be clarified. In this review, we have evaluated the utility and effectiveness of the reductionist in vitro platform to study the molecular mechanisms putatively underlying iron perturbations of neurodegenerative disease. The expression and function of iron metabolism proteins in glia and neurons and the extent to which this iron regulatory system is replicated in in vitro models has been comprehensively described, followed by an appraisal of the inherent suitability of different in vitro and ex vivo models that have been, or might be, used for iron loading. Next, we have identified and critiqued the relevant experimental parameters that have been used in in vitro iron loading experiments, including the choice of iron reagent, relevant iron loading concentrations and supplementation with serum or ascorbate, and propose optimal iron loading conditions. Finally, we have provided a synthesis of the differential iron accumulation and toxicity in glia and neurons from reported iron loading paradigms. In summary, this review has amalgamated the findings and paradigms of the published reports modelling iron loading in monocultures, discussed the limitations and discrepancies of such work to critically propose a robust, relevant and reliable model of iron loading to be used for future investigations.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ascorbic acid and iron; Brain iron; Ferric ammonium citrate; Ferric chloride; Ferrocene; Ferrous ammonium sulphate; Ferrous chloride; Ferrozine assay; In vitro models of brain iron accumulation; Iron loading in astrocytes; Iron loading in microglia; Iron loading in oligodendrocytes; Iron loading studies in primary neurons; Iron quantification; Iron reagents; Iron regulatory proteins; Iron toxicity; Organotypic brain slice cultures; Serum and iron

Mesh:

Substances:

Year:  2017        PMID: 28855100     DOI: 10.1016/j.pneurobio.2017.08.004

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  6 in total

1.  A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene.

Authors:  Shicheng Guo; Shuai Jiang; Narendranath Epperla; Yanyun Ma; Mehdi Maadooliat; Zhan Ye; Brent Olson; Minghua Wang; Terrie Kitchner; Jeffrey Joyce; Peng An; Fudi Wang; Robert Strenn; Joseph J Mazza; Jennifer K Meece; Wenyu Wu; Li Jin; Judith A Smith; Jiucun Wang; Steven J Schrodi
Journal:  Blood       Date:  2019-02-27       Impact factor: 22.113

2.  Multivariate radiomics models based on 18F-FDG hybrid PET/MRI for distinguishing between Parkinson's disease and multiple system atrophy.

Authors:  Xuehan Hu; Xun Sun; Fan Hu; Fang Liu; Weiwei Ruan; Tingfan Wu; Rui An; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-07       Impact factor: 9.236

Review 3.  The Role of Microglia in Alzheimer's Disease From the Perspective of Immune Inflammation and Iron Metabolism.

Authors:  Hui-Zhi Long; Zi-Wei Zhou; Yan Cheng; Hong-Yu Luo; Feng-Jiao Li; Shuo-Guo Xu; Li-Chen Gao
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

Review 4.  Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation.

Authors:  Changjing Wang; Tongtong Yang; Meiyu Liang; Junxia Xie; Ning Song
Journal:  Transl Neurodegener       Date:  2021-10-18       Impact factor: 8.014

5.  Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.

Authors:  Tianyu Dong; Bo Zhang; Runjiao Zhang; Chang Wang; Xiaopeng Liu; Fei Wang; Nana Hao; Ke Tan; Yan-Zhong Chang
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

6.  FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease.

Authors:  Ye Tian; Juan Lu; Xiaoqian Hao; Hang Li; Guiyu Zhang; Xuelei Liu; Xinrong Li; Caiping Zhao; Weihong Kuang; Dongfeng Chen; Meiling Zhu
Journal:  Neurotherapeutics       Date:  2020-09-21       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.